Published by Josh White on 17th July 2024
(Sharecast News) - Cell and gene therapy contract development and manufacturing organisation (CDMO) Oxford Biomedica announced the appointment of Lucinda 'Lucy' Crabtree as its new chief financial officer and a member of the board on Wednesday.
URL: http://www.digitallook.com/dl/news/story/34432454/...